pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,673 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT783Endpoints585BioPharma Dive224onclive165BioSpace59Fierce Biotech57raps24
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology
  • STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more
    Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer
    STAT · 1mo ago↗ source
  • Novocure’s electric fields therapy fails key glioblastoma study
    Novocure reported Thursday morning that its electric fields device combined with chemoradiation failed to extend glioblastoma patients' lives in a Phase 3 study, dampening the company's hopes of ex…
    Endpoints · 1mo ago↗ source
  • How many Americans can afford high-quality health care? A new poll finds the number has fallen
    A new poll shows only about half of U.S. adults could afford their health care and had access to quality care last year.
← prev
page 26 of 67
next →
6
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
STAT · 1mo ago
↗ source
  • Innoviva revives Lyndra's long-acting oral drug platform
    A healthcare asset and royalties holding company is bringing a long-acting oral medicine approach back to life, resurrecting a drug delivery platform that had accumulated more than $380 million in…
    Endpoints · 1mo ago↗ source
  • Six of the biggest health news stories today
    High-end infant formula scrutiny, the spread of synthetic opioids, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • Moderna adds commercial chief, expands Stephen Hoge's role; Reunion Neuroscience CEO departs
    → In preparation for potential new product launches, Moderna has selected Ester Banque as chief commercial officer and expanded the role of president Stephen Hoge. Banque was head of US operations…
    Endpoints · 1mo ago↗ source
  • Eli Lilly's TuneLab hits 100 members, adding Chai's AI models
    The leader behind TuneLab, Eli Lilly's first-of-its-kind AI initiative, had no idea what to expect when it launched. Lilly was trying something new by effectively offering biotechs free access to…
    Endpoints · 1mo ago↗ source
  • STAT+: In pancreatic cancer, Patrick Soon-Shiong makes promises he has not kept
    A wide gap exists between what Patrick Soon-Shiong says his cancer drugs can achieve and what they actually do, STAT's Adam Feuerstein writes.
    STAT · 1mo ago↗ source
  • Super-potent synthetic opioids called nitazenes are spreading across the U.S.
    Overdose deaths confirmed to involve nitazenes have risen sharply in the U.S., from 27 in 2020 to 409 in 2024, according to the CDC
    STAT · 1mo ago↗ source
  • Opinion: Congress should embrace strategic health diplomacy
    “Improving global health should be a top policy priority of the United States,” write Anand Parekh, Tom Daschle, and Bill Frist.
    STAT · 1mo ago↗ source
  • Opinion: AI’s growing appetite for power is a public health issue. Here’s a fix
    “AI is creating a new and largely overlooked strain on something fundamental to health,” write Sten H. Vermund and Patricia J. Kissinger.
    STAT · 1mo ago↗ source
  • New infant botulism outbreak puts fancy formulas under scrutiny
    A new infant botulism outbreak puts fancy formulas that position their products as safer than other options under scrutiny.
    STAT · 1mo ago↗ source
  • STAT+: Senate Democrats demand HHS provide records on federal vaccine policy
    Senate Democrats open an inquiry into the Trump administration’s remaking of U.S. vaccine policy, demanding officials produce records by next week.
    STAT · 1mo ago↗ source
  • What’s next for GLP-1 weight loss drugs?
    What’s next for GLP-1 weight loss drugs? Alex Hogan explores on the new episode of STATus Report. Watch now.
    STAT · 1mo ago↗ source
  • Antifungal from F2G, Shionogi succeeds in Phase 3 study
    F2G and Shionogi released positive Phase 3 data on Thursday morning, giving the companies a potentially clear path to approval for their antifungal drug. The companies said their treatment called…
    Endpoints · 1mo ago↗ source
  • Kardigan raises $400M in IPO to back three clinical-stage cardio drugs
    More evidence has arrived that biotech IPOs are alive and well: A cardiology drug developer with three clinical-stage candidates just secured $400 million for its Nasdaq debut slated for Thursday.…
    Endpoints · 1mo ago↗ source
  • Biogen makes up to $1B deal for secretive anti-inflammatory biotech
    Biogen will pay as much as $1 billion — “predominantly” in milestone payments — to acquire a San Diego biotech that has disclosed little about its pipeline. The startup, RayThera, debuted last ye…
    Endpoints · 1mo ago↗ source
  • RFK Jr. presents $700 million in mental health funding, but experts say grants aren’t new
    RFK Jr. presents funding intended to address mental illness and addiction, particularly among homeless people.
    STAT · 1mo ago↗ source
  • STAT+: DOJ’s swift win in OhioHealth case should have hospitals studying their contracts, experts say
    The speed of DOJ's proposed antitrust settlement with OhioHealth should put other hospitals on notice, experts say.
    STAT · 1mo ago↗ source
  • FDA gives rejected drugs another chance in post-Makary era
    Did you receive a complete response letter in the past year? Now may be the time for a resubmission. In the wake of FDA Commissioner Marty Makary's departure last month, the agency has already ag…
    Endpoints · 1mo ago↗ source
  • FTC, four state AGs sue transgender health group over care standards
    The FTC and four state attorneys general have sued the main professional organization for gender-affirming care clinicians.
    STAT · 1mo ago↗ source
  • NIH diversity programs doubled undergraduates’ odds of getting a Ph.D., 20-year study finds
    A new study found that two diversity-oriented programs supported by the NIH doubled the odds that an undergraduate would earn a Ph.D.
    STAT · 1mo ago↗ source
  • FDA warns telehealth companies over compounded GLP-1s
    The FDA has issued a new batch of warning letters to 25 telehealth companies, accusing them of making false and misleading claims in their marketing of compounded GLP-1 weight loss drugs. The let…
    Endpoints · 1mo ago↗ source
  • Luigi Mangione will assert psychiatric defense in murder case in UnitedHealthcare CEO’s killing
    Luigi Mangione plans to assert a psychiatric defense at his state murder trial, claiming he was suffering from extreme emotional disturbance when he gunned down UnitedHealthcare CEO Brian Thompson.
    STAT · 1mo ago↗ source
  • STAT+: Advocacy groups petition FDA to withdraw approval of ‘unsafe’ use of antibiotics given to livestock
    More than 60 organizations are urging the FDA to withdraw approval for what they called the “unsafe” use of antibiotics for preventing disease in food-producing livestock.
    STAT · 1mo ago↗ source